REQUEST A DEMO
Total
USD $0.00
Search more companies

Neomedica D.O.O. Nis (Serbia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Neomedica D.O.O. Nis Profile Updated: October 13, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Neomedica D.O.O. Nis is an enterprise in Serbia, with the main office in Nis-Mediana. It operates in the Pharmaceutical Preparation Manufacturing industry. It was established on January 15, 2001. The total number of employees is currently 58 (2020). The latest financial highlights indicate a net sales revenue increase of 2.7% in 2022. Its’ total assets recorded a negative growth of 7.33%. The enterprise’s net profit margin increased by 1.55% in 2022.

Headquarters
Bulevar Svetog Cara Konstantina 82-86
Nis-Mediana; Nis-Mediana; Postal Code: 18000

Contact Details: Purchase the Neomedica D.O.O. Nis report to view the information.

Website: http://www.neomedica.rs

Basic Information
Total Employees:
Purchase the Neomedica D.O.O. Nis report to view the information.
Outstanding Shares:
Purchase the Neomedica D.O.O. Nis report to view the information.
Registered Capital:
Purchase the Neomedica D.O.O. Nis report to view the information.
Incorporation Date:
January 15, 2001
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Neomedica D.O.O. Nis report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
2.7%
Total operating revenue
-4.12%
Operating profit (EBIT)
17.04%
EBITDA
16.31%
Net Profit (Loss) for the Period
20.78%
Total assets
-7.33%
Total equity
8.98%
Operating Profit Margin (ROS)
1.59%
Net Profit Margin
1.55%
Return on Equity (ROE)
1.95%
Debt to Equity Ratio
21.72%
Quick Ratio
-0.14%
Cash Ratio
-0.33%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?